| scholarly article | Q13442814 |
| P50 | author | Kohzoh Imai | Q11376649 |
| Minoru Toyota | Q11634024 | ||
| Yasushi Sasaki | Q73058691 | ||
| Hiromu Suzuki | Q88076551 | ||
| Yasuhisa Shinomura | Q113985398 | ||
| Reo Maruyama | Q113986045 | ||
| Masanori Nojima | Q41320164 | ||
| P2093 | author name string | Hiroaki Mita | |
| Takashi Tokino | |||
| Fumio Itoh | |||
| Takashi Imai | |||
| Kazuhiro Ogi | |||
| Hiroyoshi Hiratsuka | |||
| Kimishige Akino | |||
| Lisa Kashima | |||
| Yohei Sogabe | |||
| P2860 | cites work | High sensitivity mapping of methylated cytosines | Q24630600 |
| RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer | Q24651245 | ||
| Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing | Q24652350 | ||
| NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling | Q28144330 | ||
| Cancer and the chemokine network | Q28269751 | ||
| Hyperactive Ras in developmental disorders and cancer | Q29616397 | ||
| Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. | Q30884723 | ||
| CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations. | Q33213563 | ||
| The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer | Q34433428 | ||
| Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma | Q34570584 | ||
| The dark side of Ras: regulation of apoptosis | Q35603375 | ||
| Aberrant methylations in cancer cells: where do they come from? | Q36093347 | ||
| Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma | Q36358803 | ||
| DNA methylation as a therapeutic target in cancer | Q36760984 | ||
| Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine availability: role of nuclear factor-kappaB and activating protein-1. | Q38338844 | ||
| Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis | Q40070201 | ||
| 5-Azacytidine, a DNA methyltransferase inhibitor, induces ATR-mediated DNA double-strand break responses, apoptosis, and synergistic cytotoxicity with doxorubicin and bortezomib against multiple myeloma cells. | Q40118609 | ||
| Aberrant methylation and histone deacetylation associated with silencing of SLC5A8 in gastric cancer | Q40516629 | ||
| Interleukin 1beta enhances invasive ability of gastric carcinoma through nuclear factor-kappaB activation | Q40579930 | ||
| Gene expression profiles in human cells submitted to genotoxic stress | Q40611963 | ||
| The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas | Q40789578 | ||
| The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous-cell carcinoma | Q41590342 | ||
| Oxidative stress activates the human histidine decarboxylase promoter in AGS gastric cancer cells | Q42460524 | ||
| Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer | Q43413399 | ||
| Expression of MIP-3alpha/CCL20, a macrophage inflammatory protein in oral squamous cell carcinoma | Q44306020 | ||
| Oral cancer: the association between nation-based alcohol-drinking profiles and oral cancer mortality | Q44437747 | ||
| Frequent promoter hypermethylation of RASSF1A and p16INK4a and infrequent allelic loss other than 9p21 in betel-associated oral carcinoma in a Vietnamese non-smoking/non-drinking female population | Q45249791 | ||
| Ras oncogene and inflammation: partners in crime. | Q53674703 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 958-966 | |
| P577 | publication date | 2008-02-24 | |
| P1433 | published in | Cancer Science | Q326125 |
| P1476 | title | Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma | |
| P478 | volume | 99 |
| Q28509403 | Ablation of Rassf2 induces bone defects and subsequent haematopoietic anomalies in mice |
| Q37702087 | Cancer-associated fibroblasts promote cancer cell growth through a miR-7-RASSF2-PAR-4 axis in the tumor microenvironment |
| Q52888342 | Comparative Modeling, Molecular Docking, and Revealing of Potential Binding Pockets of RASSF2; a Candidate Cancer Gene. |
| Q52679071 | Current Insights into Oral Cancer Epigenetics. |
| Q53315728 | Decreased expression and frequent promoter hypermethylation of RASSF2 and RASSF6 correlate with malignant progression and poor prognosis of gastric cardia adenocarcinoma. |
| Q43039526 | Downregulation of tapasin expression in primary human oral squamous cell carcinoma: association with clinical outcome |
| Q41878340 | Ectopic expression of RASSF2 and its prognostic role for gastric adenocarcinoma patients |
| Q27007004 | Epigenetic disregulation in oral cancer |
| Q36602726 | Epigenetic mechanisms in oral carcinogenesis. |
| Q41162147 | Epigenetics in oral squamous cell carcinoma |
| Q33912109 | Genome-wide RNA-Sequencing analysis identifies a distinct fibrosis gene signature in the conjunctiva after glaucoma surgery |
| Q30668767 | Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation. |
| Q42184843 | Loss of RASSF2 Enhances Tumorigencity of Lung Cancer Cells and Confers Resistance to Chemotherapy |
| Q54365151 | Phospholipase C epsilon plays a suppressive role in incidence of colorectal cancer. |
| Q41231684 | Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy |
| Q24338394 | RASSF2 associates with and stabilizes the proapoptotic kinase MST2 |
| Q39120311 | RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma |
| Q45383714 | RASSF2A promoter methylation in hepatitis B virus-related hepatocellular carcinogenesis and its correlation with elevated serum alpha-fetoprotein level |
| Q38862017 | Ras signaling through RASSF proteins |
| Q33508931 | Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation |
| Q38019157 | Role of DNA methylation in head and neck cancer |
| Q24336042 | Role of the tumor suppressor RASSF2 in regulation of MST1 kinase activity |
| Q33877015 | The Ras effector RASSF2 controls the PAR-4 tumor suppressor |
| Q91940297 | The Role and Function of Ras-association domain family in Cancer: A Review |
| Q36642602 | Upregulation of β2-microglobulin expression in progressive human oral squamous cell carcinoma |
Search more.